249 related articles for article (PubMed ID: 15637093)
1. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M
Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
[TBL] [Abstract][Full Text] [Related]
2. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
Fujita M; Hayashi I; Yamashina S; Itoman M; Majima M
Biochem Biophys Res Commun; 2002 Jun; 294(2):441-7. PubMed ID: 12051731
[TBL] [Abstract][Full Text] [Related]
3. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
Ohnuma Y; Toda M; Fujita M; Hosono K; Suzuki T; Ogawa Y; Amano H; Kitasato H; Hayakawa K; Majima M
Biomed Pharmacother; 2009 Feb; 63(2):136-45. PubMed ID: 18691848
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1A receptor signaling facilitates tumor metastasis formation through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells.
Amano H; Ito Y; Ogawa F; Eshima K; Suzuki T; Oba K; Matsui Y; Kato S; Fukui T; Nakamura M; Kitasato H; Fukamizu A; Majima M
Am J Pathol; 2013 Feb; 182(2):553-64. PubMed ID: 23219751
[TBL] [Abstract][Full Text] [Related]
5. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.
Imai N; Hashimoto T; Kihara M; Yoshida S; Kawana I; Yazawa T; Kitamura H; Umemura S
Lab Invest; 2007 Feb; 87(2):189-98. PubMed ID: 17318197
[TBL] [Abstract][Full Text] [Related]
6. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
Egami K; Murohara T; Shimada T; Sasaki K; Shintani S; Sugaya T; Ishii M; Akagi T; Ikeda H; Matsuishi T; Imaizumi T
J Clin Invest; 2003 Jul; 112(1):67-75. PubMed ID: 12840060
[TBL] [Abstract][Full Text] [Related]
7. Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model.
Hayashi W; Obata Y; Nishino T; Abe S; Io K; Furusu A; Abe K; Miyazaki M; Sugaya T; Koji T; Kohno S
Nephron Exp Nephrol; 2012; 122(1-2):13-22. PubMed ID: 23446008
[TBL] [Abstract][Full Text] [Related]
8. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis.
Sasaki K; Murohara T; Ikeda H; Sugaya T; Shimada T; Shintani S; Imaizumi T
J Clin Invest; 2002 Mar; 109(5):603-11. PubMed ID: 11877468
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium.
Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T
Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305
[TBL] [Abstract][Full Text] [Related]
12. Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice.
Kurosaka M; Suzuki T; Hosono K; Kamata Y; Fukamizu A; Kitasato H; Fujita Y; Majima M
Biomed Pharmacother; 2009 Nov; 63(9):627-34. PubMed ID: 19464844
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.
Sano H; Hosokawa K; Kidoya H; Takakura N
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2673-80. PubMed ID: 16973968
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
16. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M
J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
18. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth.
Ikeda Y; Hayashi I; Kamoshita E; Yamazaki A; Endo H; Ishihara K; Yamashina S; Tsutsumi Y; Matsubara H; Majima M
Cancer Res; 2004 Aug; 64(15):5178-85. PubMed ID: 15289322
[TBL] [Abstract][Full Text] [Related]
19. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
20. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
